← SynDRA
PF-06305591
SynDRA canonical compound SYN0039489 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | SCN10A |
| Mechanism of action | sodium channel blocker |
All known targets
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- KCNA1
- SCN1A
- TDG
- SMUG1
- SCN9A
- SCN8A
- SCN5A
- SCN4A
- SCN3A
- SCN2A
- NTHL1
- KCNA2
- NEIL1
- MUTYH
- MPG
- MBD4
- KCNQ1
- KCNN2
- KCNH2
- KCNA5
- UNG
Cross-references
Synonyms
- PF-6305591
- G5Y3F1X9MU
- UNII-G5Y3F1X9MU
- RefChem:172251
- orb1710788
- SCHEMBL15157274
- SCHEMBL29571931
- APWZIFIAVVFPNT-PELKAZGASA-N
- BDBM50507839
- EX-A14325
- AKOS040734377
- DA-76771
- MS-23900
- HY-114301
- CS-0081984
- NS00073421
- G16517
- T12424
- PF-06305591 dihydrate, >=98% (HPLC)
- SCHEMBL20555197
- ZHC47397
Look up PF-06305591 in the interactive SynDRA portal →